Global position statement supporting a World Health Assembly resolution on steatotic liver disease

Authors being retrieved — see the publisher record. https://doi.org/10.1038/s41575-026-01201-z

Abstract

PubPorta does not have an abstract for this article yet.

Identifying MASLD patient eligibility for pharmacological therapy: the need to integrate evidence into clinical practice · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Microplastics, nanoplastics and liver disease: an emerging health concern? · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Precision nutrition for the prevention and management of inflammatory bowel disease · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Physical activity and the gut · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Gut microbiota induce browning of white adipose tissue · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Mechanisms and clinical outcomes linking HLA-DRB1*01:03 and IBD · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
Positive results for daraxonrasib for previously treated metastatic pancreatic cancer · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
European Congress on Obesity 2026 · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal
γδ T cells in colorectal and liver cancer · Nature Reviews Gastroenterology and Hepatology · 2026 · Same journal